translation agency

NLM AIDSLINE
Extensive impairment of triazolam and alprazolam clearance by short-term low-dose ritonavir: the clinical dilemma of concurrent inhibition and induction [editorial]
Greenblatt DJ; von Moltke LL; Daily JP; Harmatz JS; Shader RI
December 30, 1999
J Clin Psychopharmacol. 1999 Aug;19(4):293-6. Unique Identifier :

EDITORIAL REVIEW REVIEW, TUTORIAL JOURNAL ARTICLE Acquired Immunodeficiency Syndrome/*DRUG THERAPY/ENZYMOLOGY Alprazolam/*PHARMACOKINETICS Animal Cytochrome P-450/*ANTAGONISTS & INHIB/BLOOD Drug Interactions Enzyme Induction/DRUG EFFECTS Human HIV Protease Inhibitors/ADMINISTRATION & DOSAGE/*ADVERSE EFFECTS Metabolic Clearance Rate/DRUG EFFECTS Microsomes, Liver/DRUG EFFECTS/ENZYMOLOGY Oxidoreductases, N-Demethylating/*ANTAGONISTS & INHIB/BLOOD Ritonavir/ADMINISTRATION & DOSAGE/*ADVERSE EFFECTS Sedatives, Nonbarbiturate/*PHARMACOKINETICS Support, U.S. Gov't, P.H.S. Triazolam/*PHARMACOKINETICS

www.aegis.org